Related references
Note: Only part of the references are listed.Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH)
Anya Rothenbuhler et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Oral Iron for Prevention and Treatment of Rickets and Osteomalacia in Autosomal Dominant Hypophosphatemia
Wolfgang Hoegler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Elemental formula associated hypophosphataemic rickets
S. Uday et al.
CLINICAL NUTRITION (2019)
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Signe Sparre Beck-Nielsen et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: Utility of the radiographic Rickets Severity Score
Tom D. Thacher et al.
BONE (2019)
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
Erik A. Imel et al.
LANCET (2019)
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner et al.
NATURE REVIEWS NEPHROLOGY (2019)
Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial
Michael P. Whyte et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey
Alison Skrinar et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets
Nadine Meyerhoff et al.
PEDIATRIC NEPHROLOGY (2018)
Three-Month Randomized Clinical Trial of Nasal Calcitonin in Adults with X-linked Hypophosphatemia
Rebecca Sullivan et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations
Douglas Chesher et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Iron-induced hypophosphatemia: an emerging complication
Heinz Zoller et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)
Unexpected widespread hypophosphatemia and bone disease associated with elemental formula use in infants and children
Luisa F. Gonzalez Ballesteros et al.
BONE (2017)
Bovine parathyroid hormone enhances osteoclast bone resorption by modulating V-ATPase through PTH1R
Shuangxin Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Hypophosphatemic rickets and craniosynostosis: a multicenter case series
Rafael A. Vega et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2016)
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Drug-induced renal Fanconi syndrome
A. M. Hall et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2014)
Therapeutic management of hypophosphatemic rickets from infancy to adulthood
Agnes Linglart et al.
ENDOCRINE CONNECTIONS (2014)
Fibroblast Growth Factor 23 Inhibits Extrarenal Synthesis of 1,25-Dihydroxyvitamin D in Human Monocytes
Justine Bacchetta et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification
Silje Hjorth Rafaelsen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Phosphate transporters of the SLC20 and SLC34 families
Ian C. Forster et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: Long-term follow-up in one kindred
Y. Yu et al.
BONE (2012)
A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells
Shoji Ichikawa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Approach to the Hypophosphatemic Patient
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Periapical and endodontic status of permanent teeth in patients with hypophosphatemic rickets
M. G. Andersen et al.
JOURNAL OF ORAL REHABILITATION (2012)
Combined technique for the correction of lower-limb deformities resulting from metabolic bone disease
M. Kocaoglu et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2011)
A Clinician's Guide to X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Three-Year Growth Hormone Treatment in Short Children with X-Linked Hypophosphatemic Rickets: Effects on Linear Growth and Body Disproportion
M. Zivicnjak et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Calcitonin Administration in X-Linked Hypophosphatemia
Eva S. Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Loss-of-Function ENPP1 Mutations Cause Both Generalized Arterial Calcification of Infancy and Autosomal-Recessive Hypophosphatemic Rickets
Bettina Lorenz-Depiereux et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets
Emily G. Farrow et al.
BONE (2009)
Incidence and prevalence of nutritional and hereditary rickets in southern Denmark
Signe Sparre Beck-Nielsen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets
Uri S. Alon et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment
C. Chaussain-Miller et al.
ORAL DISEASES (2007)
Sagittal synostosis in X-linked hypophosphatemic rickets and related diseases
Guido Currarino
PEDIATRIC RADIOLOGY (2007)
Altered bone and mineral metabolism in patients receiving imatinib mesylate
E Berman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hypophosphatemic rickets: The role of hemiepiphysiodesis
E Novais et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2006)
The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone
D Bacic et al.
KIDNEY INTERNATIONAL (2006)
Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets:: Prevention by early treatment with 1-hydroxyvitamin D
C Chaussain-Miller et al.
JOURNAL OF PEDIATRICS (2003)
Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)(2) vitamin D-3
H Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
Share Paper
